Cyclic ADP ribose hydrolase (CD38) is another CAR candidate since it is overexpressed on AML blasts and absent on CD34+ CD38− HSC/early progenitors, as indicated by the surface markers used to classify this cell population [57]. The gene discussed is CD38; the disease is acute myeloid leukemia.